Trial intelligence / Profile preview

Nitrous oxide concentration for analgesia in postoperative ankle fracture rehabilitation

ChiCTR2500103887Phase 3Not yet recruiting

Sponsor
960th Hospital
Start
Jun 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of nitrous oxide in postoperative pain, ankle fracture and pain (4 arms), sponsored by 960th Hospital. Primary endpoint: Pain score. Planned start Jun 2025; status: not yet recruiting.

02

Drugs

nitrous oxide
03

Conditions

postoperative painankle fracturepain

Beyond the preview

Go deeper on ChiCTR2500103887.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500103887.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call